Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en
SciELO
Similares en Google
Compartir
Revista Colombiana de Cardiología
versión impresa ISSN 0120-5633
Resumen
CEBALLOS, Mateo; ARIAS, Sara y GAMBOA, Carlos. Health and economic impact of LDL cholesterol control in patients with atherosclerotic cardiovascular disease and high or very high cardiovascular risk: a simulation study for the Colombian context. Rev. Colomb. Cardiol. [online]. 2024, vol.31, n.6, pp.351-359. Epub 10-Ene-2025. ISSN 0120-5633. https://doi.org/10.24875/rccar.24000043.
Introduction:
Low-density lipoprotein cholesterol (LDL-c) is one of the modifiable risk factors with the greatest impact for atherosclerotic cardiovascular disease (ASCVD).
Objective:
To quantify the economic impact of LDL-c control in patients with ASCVD and high and very high cardiovascular risk in Colombia.
Method:
A Markov model was built from the perspective of the Colombian health-care system, to simulate the impact of a 50% reduction of LDL-c in the occurrence of major adverse cardiovascular events and direct avoided costs, over a time horizon of 5 and 10 years. The number of prevalent and incident patients and cost was quantified from public databases and local literature.
Results:
A 50% reduction in LDL-c over 5 years would prevent 105,826 events and reduce cost for the Colombian health-care system in COP $3.4 billion, a 36% decrease vs. no LDL-c control, while over 10 years these values rise to 199,583 events and COP $6 billion, a 34% reduction.
Conclusions:
In patients with ASCVD and high and very high cardiovascular risk, a sustained and consistent control of LDL-C prevents major adverse cardiovascular events and generates savings for the Colombian health-care system.
Palabras clave : LDL cholesterol; Atherosclerotic cardiovascular disease; Costs and cost analysis; Colombia.












